The Claim

Intranasal delivery of nitric oxide via spray or inhalation therapy targets the nasal mucosa, which is a primary site of SARS-CoV-2 infection due to direct environmental exposure, and this targeting offers a potential advantage for COVID-19 treatment.

Source: Nitric oxide and its derivatives containing nasal spray and inhalation therapy for the treatment of COVID-19.

What the research says

Roughly balanced

Support and challenge are close. The picture may shift as more studies come in.

Supports
1score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

This idea is about using a nose spray or breathing treatment with nitric oxide to hit the spot where COVID-19 germs first enter your body, which might help fight the infection better.

See the scientific wording

Intranasal delivery of nitric oxide via spray or inhalation therapy targets the nasal mucosa, which is a primary site of SARS-CoV-2 infection due to direct environmental exposure, offering a potential advantage for COVID-19 treatment.

What the research says

1 study

  1. Study: Nitric oxide and its derivatives containing nasal spray and inhalation therapy for the treatment of COVID-19.

    The study looks at using a nitric oxide spray in the nose to treat COVID-19, and it says this is a good idea because the virus often enters through the nose, so the spray can target it right where it starts.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.